Literature DB >> 32113834

IL-6/STAT3 mediates the HPV18 E6/E7 stimulated upregulation of MALAT1 gene in cervical cancer HeLa cells.

Yunpeng Hao1, Zhinan Yan1, Aowei Zhang1, Shiyue Hu1, Nan Wang1, Xue-Gang Luo1, Wenjian Ma1, Tong-Cun Zhang2, Hongpeng He3.   

Abstract

MALAT1, a long non-coding RNA, is highly expressed in cervical cancer cells and plays an important role in the development of cervical cancer. However, the mechanism for the excessive expression of MALAT1 in cervical cancer remains unclear. High-risk HPVs are causative agents of cervical cancer and the IL-6/STAT3 signaling is closely correlated with the development of various cancers including cervical cancer. In this study, the roles of HPV18 E6/E7 and IL-6/STAT3 in the regulation of MALAT1 transcription in cervical cancer cells were investigated. It was found that HPV18 E6/E7 activated the IL-6/STAT3 signaling and, in reciprocal, IL-6/STAT3 strengthened HPV18 E6/E7 expression in HeLa cells. Both HPV18 E6/E7 and IL-6/STAT3 were involved in MALAT1 expression and they worked synergistically in the upregulation of MALAT1 gene. With luciferase reporter assays, a STAT3-binding sequence in the enhancer region of MALAT1 gene was demonstrated to be crucial for the IL-6- or STAT3-induced MALAT1 promoter activation. Taken together, our data suggest that IL-6/STAT3 mediates the HPV18 E6/E7 stimulated upregulation of MALAT1 gene in cervical cancer HeLa cells.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cervical cancer; HPV18 E6/E7; IL-6/STAT3; MALAT1

Mesh:

Substances:

Year:  2020        PMID: 32113834     DOI: 10.1016/j.virusres.2020.197907

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  8 in total

1.  Long noncoding RNA SNHG3 promotes malignant phenotypes in cervical cancer cells via association with YAP1.

Authors:  Hongyu Zhu; Chenyu Zhu; Xiang Feng; Youzhen Luo
Journal:  Hum Cell       Date:  2021-11-24       Impact factor: 4.174

Review 2.  Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.

Authors:  Maryam Farzaneh; Sajad Najafi; Mahrokh Abouali Gale Dari; Mohadeseh Sheykhi-Sabzehpoush; Diyan Dayer; Maryam Cheraghzadeh; Shirin Azizidoost
Journal:  Clin Transl Oncol       Date:  2022-08-30       Impact factor: 3.340

3.  Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer.

Authors:  Jianfeng Zheng; Benben Cao; Xia Zhang; Zheng Niu; Jinyi Tong
Journal:  Biomed Res Int       Date:  2020-11-12       Impact factor: 3.411

Review 4.  IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma.

Authors:  Junnv Xu; Haifeng Lin; Gang Wu; Mingyue Zhu; Mengsen Li
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244

Review 5.  The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers.

Authors:  Faiza Naz; Imran Tariq; Sajid Ali; Ahmed Somaida; Eduard Preis; Udo Bakowsky
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639

6.  The Inhibitory Effect and Mechanism of Ferula akitschkensis Volatile Oil on Gastric Cancer.

Authors:  Rong Han; Yun Sun; Ruoting Ma; Dexi Wang; Jianan Sun; Shengjun Zhao; Haiying Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

Review 7.  Noncoding RNAs as sensors of tumor microenvironmental stress.

Authors:  Yue Lv; Yinghao Lv; Zhen Wang; Kefei Yuan; Yong Zeng
Journal:  J Exp Clin Cancer Res       Date:  2022-07-16

8.  The IncRNA SCIRT Promotes the Proliferative, Migratory, and Invasive Properties of Cervical Cancer Cells by Upregulating MMP-2/-9.

Authors:  Chunfeng Guan; Beibei Wang; Qixiu Dong
Journal:  J Oncol       Date:  2022-08-08       Impact factor: 4.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.